| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/09/2006 | WO2006013393A2 Quinoline derivatives as neurokinin receptor antagonists |
| 02/09/2006 | WO2005121065A3 DIAMINE β2 ADRENERGIC RECEPTOR AGONISTS |
| 02/09/2006 | WO2005108617A3 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 02/09/2006 | WO2005095409A3 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/09/2006 | US20060030710 stabilized crystal of 6-(3-chloro-2-fluorobenzyl)-1-[(S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid; anti-HIV agent |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030565 Amide derivatives and nociceptin antagonists |
| 02/09/2006 | US20060030543 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/09/2006 | CA2576073A1 Novel piperidine derivative for the treatment of depression |
| 02/09/2006 | CA2575936A1 Quinoline derivatives as neurokinin receptor antagonists |
| 02/09/2006 | CA2575697A1 Quinoline derivatives as neurokinin receptor antagonists |
| 02/09/2006 | CA2574956A1 Heterocyclic acetophenone potentiators of metabotropic glutamate receptors |
| 02/09/2006 | CA2574095A1 Quinoline derivatives and insecticide comprising thereof as active ingredient |
| 02/08/2006 | EP1623979A1 Fluorescent lanthanide complex |
| 02/08/2006 | EP1623978A1 Method for producing ethyl (3r, 5s, 6e)-7- 2-cyclopropyl-4-( 4-fluorophenyl)quinoline-3-yl -3,5-dihydroxy-6-heptenoate |
| 02/08/2006 | EP1623973A1 Platinum complex |
| 02/08/2006 | EP1622875A1 Crystalline form of aryl aniline beta-2 adrenergic receptor agonist |
| 02/08/2006 | EP1622874A1 Quinolone derivatives |
| 02/08/2006 | EP1622873A1 Method for producing the purest rac-1- {4-[2-hydroxy-3-(5-quinolyloxy)propyl] piperazin-1-yl} -2,2-diphenylethan-1-one fumarate and the purest rac-1-{ 4-[ 2-hydroxy-3-(5-quinolyloxy)propyl]piperazin-1-yl} -2,2-diphenylethan-1-one fumarate |
| 02/08/2006 | EP1622872A1 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 02/08/2006 | EP1622865A2 Novel bioisosteres of actinonin |
| 02/08/2006 | EP1358162B1 Dihydroindole and tetrahydroquinoline derivatives |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | EP0988045B1 Peptide nucleic acid monomers and oligomers |
| 02/08/2006 | EP0971587B1 Quinoline leukotriene antagonists |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1732154A Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 02/08/2006 | CN1732152A Phenethanolamine derivative for the treatment of respiratory diseases |
| 02/08/2006 | CN1240686C L-amino acid acyl -( 8-quinolyl ) amine, its derivative and preparation thereof |
| 02/08/2006 | CN1240685C Production method and use for dichloro quinolinic acid artificial hapten, artificial antigen and specific antibody |
| 02/08/2006 | CN1240684C Dibenzocycloheptene compound |
| 02/07/2006 | US6995284 Synthesis of selective androgen receptor modulators |
| 02/07/2006 | US6995269 Guanidinobenzamides |
| 02/07/2006 | US6995267 Reacting 8-bromoquinoline and bis(cyclopentadienyl)cobalt iodide, to form (quinolylcyclopentadiene)(eta-5-cyclopentadien -yl)cobalt(I), then with iron chloride to form 8-quinolylcyclopentadiene; metallocenes |
| 02/07/2006 | US6995264 Process for preparing aripiprazole |
| 02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 02/07/2006 | US6995175 Anticancer agents |
| 02/07/2006 | US6995174 for inhibiting proteases |
| 02/07/2006 | US6995170 formed by reacting 7-halogeno-8-cyano-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid with (1S,6S)-2,8-diazabicyclo[4.3.0]nonane in presence of base/diluent; for use as antibacterial agent |
| 02/07/2006 | US6995156 Platelet adenosine diphosphate receptor antagonists |
| 02/02/2006 | WO2006011047A1 Enantioselective method for separing substituted 2-trifluoromethyl-2h-chromene-3-carboxylic acid derivatives |
| 02/02/2006 | WO2006010831A1 4-substituted quinoline derivatives, method and intermediates for preparing same and pharmaceutical compositions containing same |
| 02/02/2006 | WO2006010775A1 Tyrosine derivatives as ppar-gamma-modulators |
| 02/02/2006 | US20060025592 Lysine based compounds |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis |
| 02/02/2006 | CA2574363A1 Enantioselective method for separating sustituted 2-trifluoromethyl-2h-chromene-3-carboxylic acid derivatives |
| 02/02/2006 | CA2574021A1 Tyrosine derivatives as ppar-gamma-modulators |
| 02/02/2006 | CA2571668A1 4-substituted quinoline derivatives, method and intermediates for preparing same and pharmaceutical compositions containing same |
| 02/02/2006 | CA2570903A1 N-hydroxyamide derivatives and use thereof |
| 02/01/2006 | EP1621198A2 Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists |
| 02/01/2006 | EP1620102A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 02/01/2006 | EP1620086A1 Compounds that modulate ppar activity and methods of preparation |
| 02/01/2006 | EP1383734B1 Compounds useful as intermediates for 4-aminoquinoline derivatives |
| 02/01/2006 | EP1341774B1 Fused heteroaromatic glucokinase activators |
| 02/01/2006 | CN1729176A Tetrahydroquinoline derivatives and their use as FSH receptor modulators |
| 02/01/2006 | CN1729175A Tetrahydroquinoline derivatives |
| 02/01/2006 | CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/01/2006 | CN1729157A Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 02/01/2006 | CN1239467C Primary intermediates for oxidative coloration of hair |
| 02/01/2006 | CN1239154C 5-HT IA receptor subtype agonist |
| 01/31/2006 | US6991857 Metal coordination compound, luminescence device and display apparatus |
| 01/26/2006 | WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/26/2006 | WO2006008562A1 Process |
| 01/26/2006 | WO2005097134A3 Quinazoline based protein kinase inhibitors |
| 01/26/2006 | WO2005086844A9 Magnetism to control friction checks for rods |
| 01/26/2006 | WO2001085170A9 Peptide deformylase inhibitors |
| 01/26/2006 | US20060020132 high binding efficiencies between D3 and D2 dopaminergic receptor subtypes; drug abuse, drug dependence |
| 01/26/2006 | US20060020022 Enantioselective separation method |
| 01/26/2006 | US20060019973 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide |
| 01/26/2006 | US20060019947 Therapeutic chromone compounds |
| 01/26/2006 | US20060019906 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 01/26/2006 | US20060018825 Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 01/26/2006 | DE10223908B4 Verfahren zur Herstellung von substituierten Pyridinen A process for the preparation of substituted pyridines |
| 01/26/2006 | CA2574464A1 Substituted quinolones |
| 01/26/2006 | CA2574362A1 Process |
| 01/26/2006 | CA2574237A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/26/2006 | CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/25/2006 | EP1619180A1 CaSR ANTAGONIST |
| 01/25/2006 | EP1618103A2 Polymorphs of aripiprazole |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | EP1446224B1 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions |
| 01/25/2006 | CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 01/25/2006 | CN1726185A Formulations comprising selective androgen receptor modulators and using method thereof |
| 01/25/2006 | CN1726034A Methylene-bridged selective androgen receptor modulators and methods of use thereof |
| 01/25/2006 | CN1238337C Pesticide |
| 01/24/2006 | US6989468 Oxoperoxotungsten(VI) complex catalysts |
| 01/24/2006 | US6989447 Compounds |
| 01/24/2006 | US6989392 2-Aminoquinolines as melanin concentrating hormone receptor antagonists |
| 01/24/2006 | US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/24/2006 | CA2187525C Quinolone derivative for treatment of urinary incontinence |
| 01/19/2006 | WO2006006573A1 Filter and cyanine compound |
| 01/19/2006 | WO2005097746A3 2-propene-1-ones as hsp 70 inducers |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | US20060014830 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 01/19/2006 | US20060014788 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/19/2006 | US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/19/2006 | US20060014783 Sulfonylamino-acetic acid derivatives |